Viewing Study NCT02769559


Ignite Creation Date: 2025-12-24 @ 2:38 PM
Ignite Modification Date: 2026-01-13 @ 5:31 AM
Study NCT ID: NCT02769559
Status: COMPLETED
Last Update Posted: 2016-05-12
First Post: 2016-05-10
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Reduction Mammaplasty and Improved Quality of Life
Sponsor: University Hospital Bratislava
Organization:

Study Overview

Official Title: Reduction Mammaplasty Safely Increases the Quality of Life in Patients With Mammary Hypetrophy.
Status: COMPLETED
Status Verified Date: 2016-05
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: MammaRed
Brief Summary: The data gathered here will be used to evaluate the efficacy and safety of the mammary reduction in patients with macromastia.
Detailed Description: The data was gathered using retrospective and follow-up prospective study of a group of patients, consisting of adult women that underwent a breast reduction surgery at the Clinic of Plastic, Reconstructive and Aesthetic Surgery Faculty of Comenius University and at the University Hospital in Bratislava, Ružinov, during the time period between 2000 until May 2014. The data concerning the quality of life of these patients was gathered by using the globally standardized questionnaire "Breast Q questionnaire©" with the separate software system evaluation tool "QScore©". The statistical analysis was conducted using GraphpadPrism program v. 6.01. The total number of respondents consisted of 52 people who were followed-up for up to 12 years.

Study Oversight

Has Oversight DMC: False
Is a FDA Regulated Drug?: None
Is a FDA Regulated Device?: None
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: